摘要
目的探讨可必特联合普米克令舒雾化吸入佐治毛细支气管炎的疗效。方法选择我院2006年1月-2008年10月支气管肺炎住院患儿72例，随机分为治疗组39例，对照组33例；两组患儿均采用吸氧、抗病毒、抗炎、止咳、祛痰、平喘等治疗。治疗组加用可必特及普米克令舒联合雾化吸入，对治疗后症状、体征消失时间以及治愈率进行比较。结果咳嗽消失、缓解喘憋及缩短肺部啰音时间均明显优于对照组，两组比较有显著性差异（P〈0．05）。治疗组治愈率为97．44％，对照组治愈率为66．67％。结论可必特及普米克令舒雾化吸入佐治毛细支气管炎有显著疗效，适合婴幼儿使用。
Objective To evaluate the clinical efficacy of kebite combivent and aerosol budesonide suspension on infants bronchinlitis. Methods A total of 72 patients with bronchial pneumonia were recruited from January 2006 to December 2008. The age range were from 27 days to 2 years （8 months average） The therapy group （39 cases randomly） were treated with Kebite Combivent and aerosol budesonide suspension （driving the airgun with 6L/ml oxygen）, while the control group （33 cases） with traditional treatment （ β2-receptor agonist orally or aminophylline intravenously）. Both were treated with anti-infection treatments in the same time. Therapeutic effects were evaluated 7 days later, Results The healing rate of therapy group was 97.44% and that of control group was 66.67%. Both of them were significant difference （P〈 0.05）. Concluaion Association with Kebite Combivent and aerosol budesonide suspension is an effective, convenient treatment for infants＇ bronchiolitis with little side effects.
出处
《国际医药卫生导报》
2009年第7期67-69,共3页
International Medicine and Health Guidance News
关键词
支气管肺炎
可必特
普米克令舒
雾化吸入
Bronehopneumonia
Kehite
Budesonide suspension
Atomization and inhalation
